US 8829024
Combination steroid and glucocorticoid receptor antagonist therapy
granted A61KA61K31/437A61K31/573
Quick answer
US patent 8829024 (Combination steroid and glucocorticoid receptor antagonist therapy) held by Corcept Therapeutics Incorporated expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/437, A61K31/573, A61K45/06, A61P